Received Apr 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | FJ6369 | SYR / RA |
Injection received February 2022. Patient had extreme back pain through December 2022, leaving employment 1/5/2023. Suffered Drop Foot and limited mobility 1/18/2023. Sent to emergency room due to lack of ability to urinate or have bowel movements 1/23/2023. Resulting MRI revealed tumor of the spine. Surgery to remove tumor took place 1/31/2023. Standard of care chemotherapy and radiation took place, followed by inpatient acute rehabilitation. A clinical trial for trial medication ONC201 was started to assist in stopping the cancer. Seizures began 8/31/2024, resulting in Coma for about 5 days. Patient passed away from metastasis to brain 10/15/2024.
None
Asthma
Daily multi-vitamins
None at the time